120 related articles for article (PubMed ID: 33832119)
1. A simple method for discrimination of carcinomatous meningitis using CEA, total protein, and total cell count in the cerebrospinal fluid of primary lung cancer patients.
Ogawa Y; Saraya T; Noda A; Kurokawa N; Sakuma S; Aso K; Mikura S; Oda M; Ishida M; Honda K; Nakamoto K; Tamura M; Takata S; Ishii H; Takizawa H
Medicine (Baltimore); 2021 Apr; 100(14):e25367. PubMed ID: 33832119
[TBL] [Abstract][Full Text] [Related]
2. The concentration of CYFRA 21-1, NSE and CEA in cerebro-spinal fluid can be useful indicators for diagnosis of meningeal carcinomatosis of lung cancer.
Wang P; Piao Y; Zhang X; Li W; Hao X
Cancer Biomark; 2013; 13(2):123-30. PubMed ID: 23838141
[TBL] [Abstract][Full Text] [Related]
3. [Auxiliary Diagnostic Value of Tumor Markers in the Cerebrospinal Fluid and Blood for Leptomeningeal Metastasis from Non-small Cell Lung Cancer].
Lin Y; Li H; Huang M; Yin Z; Wu J
Zhongguo Fei Ai Za Zhi; 2020 Jun; 23(6):516-525. PubMed ID: 32517459
[TBL] [Abstract][Full Text] [Related]
4. Added Diagnostic Value of Cerebrospinal Fluid Carcinoembryonic Antigen in a Patient with Leptomeningeal Carcinomatosis as the Initial Manifestation of Gastric Cancer.
Ino R; Sada KE; Miyauchi A; Hashimoto D; Nojima S; Yamanaka S; Kawamura M
Acta Med Okayama; 2021; 75(5):659-661. PubMed ID: 34703051
[TBL] [Abstract][Full Text] [Related]
5. Intrathecal synthesis of tumor markers is a highly sensitive test in the diagnosis of leptomeningeal metastasis from solid cancers.
Corsini E; Bernardi G; Gaviani P; Silvani A; de Grazia U; Ciusani E; Croci D; Salmaggi A
Clin Chem Lab Med; 2009; 47(7):874-9. PubMed ID: 19453289
[TBL] [Abstract][Full Text] [Related]
6. Lactate dehydrogenase as a prognostic marker in neoplastic meningitis.
Cacho-Díaz B; Lorenzana-Mendoza NA; Reyes-Soto G; Hernández-Estrada A; Monroy-Sosa A; Guraieb-Chahin P; Cantu-de-León D
J Clin Neurosci; 2018 May; 51():39-42. PubMed ID: 29483012
[TBL] [Abstract][Full Text] [Related]
7. Changes of cerebrospinal fluid tumor marker levels may predict response to treatment and survival of carcinomatous meningitis in patients with advanced breast cancer.
Kosmas C; Tsavaris NB; Soukouli G; Gouveris P; Tsakonas G; Katselis J; Alexopoulos H; Mylonakis N; Karabelis A
Med Oncol; 2005; 22(2):123-8. PubMed ID: 15965274
[TBL] [Abstract][Full Text] [Related]
8. Evaluating the cerebrospinal fluid ctDNA detection by next-generation sequencing in the diagnosis of meningeal Carcinomatosis.
Zhao Y; He JY; Zou YL; Guo XS; Cui JZ; Guo L; Bu H
BMC Neurol; 2019 Dec; 19(1):331. PubMed ID: 31856745
[TBL] [Abstract][Full Text] [Related]
9. Measurements of CSF biochemical tumor markers in patients with meningeal carcinomatosis and brain tumors.
Nakagawa H; Kubo S; Murasawa A; Nakajima S; Nakajima Y; Izumoto S; Hayakawa T
J Neurooncol; 1992 Feb; 12(2):111-20. PubMed ID: 1560255
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal Fluid Analysis.
Shahan B; Choi EY; Nieves G
Am Fam Physician; 2021 Apr; 103(7):422-428. PubMed ID: 33788511
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of cerebrospinal fluid tumor cell count in leptomeningeal disease from solid tumors.
Barbour AB; Blouw B; Taylor LP; Graber JJ; McGranahan T; Blau M; Halasz LM; Lo SS; Tseng YD; Venur V; Yang JT
J Neurooncol; 2024 May; 167(3):509-514. PubMed ID: 38441840
[TBL] [Abstract][Full Text] [Related]
12. An NMR metabolomics approach for the diagnosis of leptomeningeal carcinomatosis in lung adenocarcinoma cancer patients.
An YJ; Cho HR; Kim TM; Keam B; Kim JW; Wen H; Park CK; Lee SH; Im SA; Kim JE; Choi SH; Park S
Int J Cancer; 2015 Jan; 136(1):162-71. PubMed ID: 24798643
[TBL] [Abstract][Full Text] [Related]
13. [Associated factors with the presence of secondary neoplastic cells in the cerebrospinal fluid of patients with suspected carcinomatous meningitis].
Warley F; Bonella MB; Giunta DH; Elizondo CM; Ferreyro BL
Rev Fac Cien Med Univ Nac Cordoba; 2017; 74(1):26-32. PubMed ID: 28379128
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical demonstration of carcinoembryonic antigen in cerebrospinal fluid with carcinomatous meningitis from rectal cancer.
Kobayashi TK; Yamaki T; Yoshino E; Higuchi T; Kamachi M
Acta Cytol; 1984; 28(4):430-4. PubMed ID: 6380184
[TBL] [Abstract][Full Text] [Related]
15. Elevation of carcinoembryonic antigen in cerebrospinal fluid among patients with meningeal carcinomatosis.
Klee GG; Tallman RD; Goellner JR; Yanagihara T
Mayo Clin Proc; 1986 Jan; 61(1):9-13. PubMed ID: 3510343
[TBL] [Abstract][Full Text] [Related]
16. Cerebrospinal fluid tumour markers in patients treated for meningeal malignancy.
van Zanten AP; Twijnstra A; Ongerboer de Visser BW; van Heerde P; Hart AA; Nooyen WJ
J Neurol Neurosurg Psychiatry; 1991 Feb; 54(2):119-23. PubMed ID: 2019836
[TBL] [Abstract][Full Text] [Related]
17. SHP-1 promoter 2 methylation in cerebrospinal fluid for diagnosis of leptomeningeal epithelial-derived malignancy (carcinomatous meningitis).
Vinayanuwattikun C; Mingmalairak S; Jittapiromsak N; Thaipisuttikul I; Sriuranpong V; Mutirangura A; Shuangshoti S
J Neurooncol; 2016 Sep; 129(3):395-403. PubMed ID: 27401153
[TBL] [Abstract][Full Text] [Related]
18. Analysis of Cerebrospinal Fluid and Serum CEA Concentration in Non-neoplastic Diseases.
Shi Q; Tian C; Huang X; Pu C
Ann Clin Lab Sci; 2016; 46(2):180-3. PubMed ID: 27098625
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen in cerebrospinal fluid of adult brain-tumor patients.
Hill S; Martin E; Ellison EC; Hunt WE
J Neurosurg; 1980 Nov; 53(5):627-32. PubMed ID: 7431072
[TBL] [Abstract][Full Text] [Related]
20. Leptomeningeal metastasis: Clinical experience of 519 cases.
Hyun JW; Jeong IH; Joung A; Cho HJ; Kim SH; Kim HJ
Eur J Cancer; 2016 Mar; 56():107-114. PubMed ID: 26841095
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
